HEA BeadChip™ technology in immunohematology
By:
Paid access
|Oct 2019References
- Reid ME. Transfusion in the age of molecular diagnostics. Hematology 2009;171–7.
- Reid ME, Lomas-Francis C, Olsson L. The blood group antigen. FactsBook. 3rd ed. London: Elsevier, 2012.
- Reid ME, Denomme GA. DNA-based methods in the immunohematology reference laboratory. Transfus Apher Sci 2011;44:65–72.
- Denomme GA. Molecular basis of blood group expression. Transfus Apher Sci 2011;44:53–63.
- Denomme GA, Johnson ST, Pietz BC. Mass-scale red cell genotyping of blood donors. Transfus Apher Sci 2011;44:93–9.
- Hashmi G, Shariff T, Seul M, et al. A flexible array format for large-scale, rapid blood group DNA typing. Transfusion 2005;45:680–8.
- Hashmi G, Shariff T, Zhang Y, et al. Determination of 24 minor red blood cell antigens for more than 2000 blood donors by high-throughput DNA analysis. Transfusion 2007;47:736–47.
- Castilho L. The value of DNA analysis for antigen in the Duffy blood group system. Transfusion 2007;47(1 Suppl):28S–31S.
- Nataf J, Poupl S, Gien D, et al. The rare Dantu phenotype: serologic aspects and new screening approach through red blood cell (RBC) genotyping. Transfusion 2013;53(2 Suppl):48A.
- Crowley JA, Colvin CJ, Horn T, et al. Unexpected HEA BeadChip™ findings point to unusual variant GYPB alleles. Transfusion 2014;54(2 Suppl):46A.
- Vichinsky EP, Earles A, Johnson RA, et al. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990;322:1617–21.
- Aygun B, Padmanabhan S, Paley C, et al. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusion. Transfusion 2002;42:37–43.
- Schonewille H, de Vries RR, Brand A. Alloimmune response after additional red blood cell antigen challenge in immunized hematooncology patients. Transfusion 2009;49:453–7.
- Tahhan HR, Holbrook CT, Braddy LR, et al. Antigen-matched donor blood in the transfusion management of patients with sickle cell disease. Transfusion 1994;34:562–9.
- Vichinsky EP, Luban NLC, Wright E, et al. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 2001;41:1086–92.
- LaSalle-Williams M, Nuss R, Le T, et al. Extended red blood cell antigen matching for transfusion in sickle cell disease: a review of a 14-year experience from a single center. Transfusion 2011;51:1732–9.
- Matteocci A, Pierelli L. Red blood cell alloimmunization in sickle cell disease and in thalassaemia: current status, future perspectives and potential role of molecular typing. Vox Sang 2014;106:197–208.
- Hillyer CD, Shaz BH, Winkler AM, et al. Integrating molecular technologies for red blood cell typing and compatibility testing into blood centers and transfusion services. Transfus Med Rev 2008;22:117–32.
- Jungbauer C. Routine use of DNA testing for red cell antigens in blood centres. Transfus Apher Sci 2011;45:61–8.
- Veldhuisen B, van der Schoot CE, de Haas M. Blood group genotyping: from patient to high-throughput donor screening. Vox Sang 2009;97:198–206.
- Moulds JM. Implementation of HEA at blood centers: prescreening, rare donors, inventory management. In: BeadChip molecular immunohematology. Toward routine donor and patient antigen profiling by DNA analysis. Moulds JM, Ness PM, Sloan SR, eds. Springer, New York, 2011:33–56.
- Klapper E. Implementation of HEA BeadChip™ system at medical centers: providing extended matched units and eliminating complex workups for patients. In: BeadChip molecular immunohematology. Toward routine donor and patient antigen profiling by DNA analysis. Moulds JM, Ness PM, Sloan SR, eds. Springer, New York, 2011:57–71.
- Sapatnekar S, Figueroa PI. How do we use molecular red blood cell antigen typing to supplement pretransfusion testing? Transfusion 2014;54:1452–8.
- Strauss D, Reid ME. Value of DNA-based assays for donor screening and regulatory issues. Immunohematology 2008;24:175–9.
- Shafi H, Abumuhor I, Klapper E. How we incorporate molecular typing of donors and patients into our hospital transfusion service. Transfusion 2014;54:1212–9.
- Badjie KSW, Tauscher C, Van Buskirk C, et al. Red blood cell phenotype matching for various ethnic groups. Immunohematology 2011;27:12–8.
- Klapper E, Zhang Y, Figueroa P, et al. Toward extended phenotype matching: a new operational paradigm for the transfusion service. Transfusion 2010;50:536–46.
- Wilkinson K, Harris S, Gaur P, et al. Molecular blood typing augments serologic testing and allows for enhanced matching of red blood cells for transfusion in patients with sickle cell disease. Transfusion 2012;52:381–8.
- Flickinger C, Meny G, Nance SJ. The ongoing need for rare blood donors. Transfusion 2014;54(2 Suppl):154A.
- Remeikiene D, Ugenskiene R, Inciura A, et al. Duffy and Kidd genotyping facilitates pre-transfusion testing in patients undergoing long-term transfusion therapy. Turk J Haematol 2014;31:367–73.
- Bakanay SM, Ozturk A, Ileri T, et al. Blood group genotyping in multi-transfused patients. Transfus Apher Sci 2013;48: 257–61.
- El Kenz H, Efira A, Le PQ, et al. Transfusion support of autoimmune hemolytic anemia: how could the blood group genotyping help? Transl Res 2014;163:36–42.
- Crews WS, Parsons B, Sutor LJ, et al. Molecular genotyping and modification of pretransfusion testing will decrease cost and turnaround time (TAT) for patients requiring complex antibody workups. Transfusion 2014:54(2 Suppl):153A.
- Ribeiro KR, Guarnieri MH, da Costa DC, et al. DNA array analysis for red blood cell antigens facilitates the transfusion support with antigen-matched blood in patients with sickle cell disease. Vox Sang 2009;97:147–52.
- da Costa DC, Pellegrino JJR, Guelsin GAS, et al. Molecular matching of red blood cells is superior to serological matching in sickle cell disease patients. Rev Bras Hematol Hemoter 2013;35:35–8.
- Flickinger C, Keller MA, Meny G, et al. Providing units for patients with anti-E and antibodies to hrB, hrS or e variants: an update. Transfusion 2014;54(2 Suppl):149A.
- Gaspardi AC, Sippert E, Carvalho C, et al. Applying molecular assays to enhanced immunohematology and guide selection of antigen-matched red blood cell components for transfusion. Transfusion 2014;54(2 Suppl):154A.
- Revelli N, Villa MA, Paccapelo C, et al. The Lombardy Rare Donor Programme. Blood Transfus 2014;12(Suppl 1): S249–55.
- Singleton BK, Burton NM, Green C, et al. Mutations in EKLF/ KLF1 form the molecular basis of the rare blood group In(Lu) phenotype. Blood 2008;112:2081–8.
DOI: https://doi.org/10.21307/immunohematology-2019-075 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 81 - 90
Published on: Oct 26, 2019
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
Related subjects:
© 2019 C. Paccapelo, F. Truglio, M.A. Villa, N. Revelli, M. Marconi, published by American National Red Cross
This work is licensed under the Creative Commons License.